Exact Mass: 692.1589

Exact Mass Matches: 692.1589

Found 33 metabolites which its exact mass value is equals to given mass value 692.1589, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Guanosine diphosphate adenosine

{[(2R,3R,4R,5R)-4-[({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid

C20H26N10O14P2 (692.1105)


Guanosine diphosphate adenosine is a dinucleoside polyphosphate. Dinucleoside polyphosphates are an interesting group of signalling molecules that control numerous physiological functions. Diadenosine compounds, with a backbone of anything from two to seven phosphates, are known to occur naturally. Some of them have been isolated from cerebral nerve terminals and, acting via nucleoside (P1), nucleotide (P2), or dinucleotide receptors, can affect central nervous system function. Many of them have been isolated from human blood platelet secretory granules and are potentially involved in haemostatic mechanisms and peripheral control of vascular tone. Many visceral organs respond to the application of adenine dinucleotides and, although they act on receptors in the periphery that can be mainly defined as either P1 or P2, evidence is now accumulating for discrete dinucleotide receptors. In the periphery, adenine dinucleotides can be potent agonists, with diverse functions, causing contraction or relaxation of smooth muscle. Many P2X receptor proteins and P2Y receptors have been cloned and adenine dinucleotides have a variable pharmacological profile at these receptors and may be useful tools for characterising subtypes of P2X and P2Y receptors. Many extracellular roles of diadenosine polyphosphates are emerging as yet increasingly important, natural ligands for a plethora of structurally diverse mononucleotide and dinucleotide receptors. (PMID: 12772275, 7767329) [HMDB] Guanosine diphosphate adenosine is a dinucleoside polyphosphate. Dinucleoside polyphosphates are an interesting group of signalling molecules that control numerous physiological functions. Diadenosine compounds, with a backbone of anything from two to seven phosphates, are known to occur naturally. Some of them have been isolated from cerebral nerve terminals and, acting via nucleoside (P1), nucleotide (P2), or dinucleotide receptors, can affect central nervous system function. Many of them have been isolated from human blood platelet secretory granules and are potentially involved in haemostatic mechanisms and peripheral control of vascular tone. Many visceral organs respond to the application of adenine dinucleotides and, although they act on receptors in the periphery that can be mainly defined as either P1 or P2, evidence is now accumulating for discrete dinucleotide receptors. In the periphery, adenine dinucleotides can be potent agonists, with diverse functions, causing contraction or relaxation of smooth muscle. Many P2X receptor proteins and P2Y receptors have been cloned and adenine dinucleotides have a variable pharmacological profile at these receptors and may be useful tools for characterising subtypes of P2X and P2Y receptors. Many extracellular roles of diadenosine polyphosphates are emerging as yet increasingly important, natural ligands for a plethora of structurally diverse mononucleotide and dinucleotide receptors. (PMID: 12772275, 7767329).

   

Bisphenol A bis(diphenyl phosphate)

4-(2-{4-[(diphenoxyphosphoryl)oxy]phenyl}propan-2-yl)phenyl diphenyl phosphoric acid

C39H34O8P2 (692.1729)


   
   

Ganbajunin A

Ganbajunin A

C43H32O9 (692.2046)


   

6-Methoxykaempferol 3,7-bis(3-acetylrhamnoside)

3,7-Bis [ (3-O-acetyl-alpha-L-rhamnopyranosyl) oxy ] -4,5-dihydroxy-6-methoxyflavone

C32H36O17 (692.1952)


   
   
   

3,4,5-Tri-O-caffeoylquinic acid methyl ester

3,4,5-Tri-O-caffeoylquinic acid methyl ester

C35H32O15 (692.1741)


   
   

7-O-[2-O-(5-O-sinapoyl-beta-D-apiofuranosyl)-beta-D-glucopyranosyl]-6-methoxycoumarin|obtusifoside G

7-O-[2-O-(5-O-sinapoyl-beta-D-apiofuranosyl)-beta-D-glucopyranosyl]-6-methoxycoumarin|obtusifoside G

C32H36O17 (692.1952)


   

hopeachinol C

hopeachinol C

C42H28O10 (692.1682)


   

7-O-[6-O-(5-O-sinapoyl-beta-D-apiofuranosyl)-beta-D-glucopyranosyl]-6-methoxycoumarin|obtusifoside F

7-O-[6-O-(5-O-sinapoyl-beta-D-apiofuranosyl)-beta-D-glucopyranosyl]-6-methoxycoumarin|obtusifoside F

C32H36O17 (692.1952)


   

beta-Naphthocyclinon-epoxid|Beta-Naphthocyclinone epoxide

beta-Naphthocyclinon-epoxid|Beta-Naphthocyclinone epoxide

C35H32O15 (692.1741)


   

3,5-di-O-(beta-Glucopyranosyl) pelargonidin 6-O-4, 6-O-1-cyclic malate

3,5-di-O-(beta-Glucopyranosyl) pelargonidin 6-O-4, 6-O-1-cyclic malate

C31H32O18 (692.1589)


   

Guanosine diphosphate adenosine

Guanosine diphosphate adenosine

C20H26N10O14P2 (692.1105)


   

bis[2-[[4-(dimethylamino)phenyl]azo]-1,3-dimethyl-1H-imidazolium] tetrachlorozincate(2-)

bis[2-[[4-(dimethylamino)phenyl]azo]-1,3-dimethyl-1H-imidazolium] tetrachlorozincate(2-)

C26H36Cl4N10Zn (692.117)


   

[3,3-(7,12-diethenyl-3,8,13,17-tetramethyl-20-phenylporphyrin-2,18-diyl-kappa~4~N~21~,N~22~,N~23~,N~24~)dipropanoato(2-)]iron(2+)

[3,3-(7,12-diethenyl-3,8,13,17-tetramethyl-20-phenylporphyrin-2,18-diyl-kappa~4~N~21~,N~22~,N~23~,N~24~)dipropanoato(2-)]iron(2+)

C40H36FeN4O4 (692.2086)


   

[(2R,3R,4R,5R)-2-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methyl hydrogen phosphate

[(2R,3R,4R,5R)-2-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methyl hydrogen phosphate

C20H26N10O14P2 (692.1105)


   

5-O-Phosphonoadenylyl-(3-->5)-guanosine

5-O-Phosphonoadenylyl-(3-->5)-guanosine

C20H26N10O14P2 (692.1105)


   

[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] [(2R,3S,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] [(2R,3S,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

C20H26N10O14P2 (692.1105)


   

Guanylyl-(3-->5)-3-adenylic acid

Guanylyl-(3-->5)-3-adenylic acid

C20H26N10O14P2 (692.1105)


   

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R)-3,4-dihydroxy-5-[(6-oxo-1,7-dihydropurin-2-yl)amino]oxolan-2-yl]methyl hydrogen phosphate

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R)-3,4-dihydroxy-5-[(6-oxo-1,7-dihydropurin-2-yl)amino]oxolan-2-yl]methyl hydrogen phosphate

C20H26N10O14P2 (692.1105)


   

methyl 3,4,5-tris({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylate

methyl 3,4,5-tris({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylate

C35H32O15 (692.1741)


   

(1r,4r,9r)-9-[(1s,4s,7s,8s,9s)-7,8-dihydroxy-4-(hydroxymethyl)-5-methyl-3,6-dioxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl]-4-isopropyl-5-methyl-4-(methyldisulfanyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-7,10,12,14-tetraene-3,6-dione

(1r,4r,9r)-9-[(1s,4s,7s,8s,9s)-7,8-dihydroxy-4-(hydroxymethyl)-5-methyl-3,6-dioxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl]-4-isopropyl-5-methyl-4-(methyldisulfanyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-7,10,12,14-tetraene-3,6-dione

C33H36N6O7S2 (692.2087)


   

8,20-dihydroxy-19-(hydroxymethyl)-5-(4-hydroxyphenyl)-7,9-dimethoxy-19-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,15,18-trioxatetracyclo[15.2.1.0⁴,¹³.0⁶,¹¹]icosa-6(11),7,9,12-tetraene-3,14-dione

8,20-dihydroxy-19-(hydroxymethyl)-5-(4-hydroxyphenyl)-7,9-dimethoxy-19-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,15,18-trioxatetracyclo[15.2.1.0⁴,¹³.0⁶,¹¹]icosa-6(11),7,9,12-tetraene-3,14-dione

C32H36O17 (692.1952)


   

methyl (1s,3r,4s,5r)-3,4,5-tris({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylate

methyl (1s,3r,4s,5r)-3,4,5-tris({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-1-hydroxycyclohexane-1-carboxylate

C35H32O15 (692.1741)


   

15,23-dihydroxy-3,11,19-tris(4-hydroxyphenyl)-4,12,20-trioxaheptacyclo[16.6.1.1²,⁵.1¹⁰,¹³.0²¹,²⁵.0⁹,²⁷.0¹⁷,²⁶]heptacosa-1(24),5,9(27),13(26),14,16,21(25),22-octaene-7,8-dione

15,23-dihydroxy-3,11,19-tris(4-hydroxyphenyl)-4,12,20-trioxaheptacyclo[16.6.1.1²,⁵.1¹⁰,¹³.0²¹,²⁵.0⁹,²⁷.0¹⁷,²⁶]heptacosa-1(24),5,9(27),13(26),14,16,21(25),22-octaene-7,8-dione

C42H28O10 (692.1682)


   

(2r,3r,10r,11s,18r,19r)-15,23-dihydroxy-3,11,19-tris(4-hydroxyphenyl)-4,12,20-trioxaheptacyclo[16.6.1.1²,⁵.1¹⁰,¹³.0²¹,²⁵.0⁹,²⁷.0¹⁷,²⁶]heptacosa-1(24),5,9(27),13(26),14,16,21(25),22-octaene-7,8-dione

(2r,3r,10r,11s,18r,19r)-15,23-dihydroxy-3,11,19-tris(4-hydroxyphenyl)-4,12,20-trioxaheptacyclo[16.6.1.1²,⁵.1¹⁰,¹³.0²¹,²⁵.0⁹,²⁷.0¹⁷,²⁶]heptacosa-1(24),5,9(27),13(26),14,16,21(25),22-octaene-7,8-dione

C42H28O10 (692.1682)


   

methyl 2-[3-hydroxy-2-(methoxycarbonyl)-5-methylphenoxy]-5-{2-hydroxy-6-[4-hydroxy-2-methoxy-6-(methoxycarbonyl)phenoxy]-4-methylbenzoyloxy}-3-methoxybenzoate

methyl 2-[3-hydroxy-2-(methoxycarbonyl)-5-methylphenoxy]-5-{2-hydroxy-6-[4-hydroxy-2-methoxy-6-(methoxycarbonyl)phenoxy]-4-methylbenzoyloxy}-3-methoxybenzoate

C35H32O15 (692.1741)


   

(1s,4r,5s,17r,19s,20r)-8,20-dihydroxy-19-(hydroxymethyl)-5-(4-hydroxyphenyl)-7,9-dimethoxy-19-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,15,18-trioxatetracyclo[15.2.1.0⁴,¹³.0⁶,¹¹]icosa-6(11),7,9,12-tetraene-3,14-dione

(1s,4r,5s,17r,19s,20r)-8,20-dihydroxy-19-(hydroxymethyl)-5-(4-hydroxyphenyl)-7,9-dimethoxy-19-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,15,18-trioxatetracyclo[15.2.1.0⁴,¹³.0⁶,¹¹]icosa-6(11),7,9,12-tetraene-3,14-dione

C32H36O17 (692.1952)


   

(1r,4s,9r)-9-[(1s,4s,7s,8s,9r)-7,8-dihydroxy-4-(hydroxymethyl)-5-methyl-3,6-dioxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl]-4-isopropyl-5-methyl-4-(methyldisulfanyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-7,10,12,14-tetraene-3,6-dione

(1r,4s,9r)-9-[(1s,4s,7s,8s,9r)-7,8-dihydroxy-4-(hydroxymethyl)-5-methyl-3,6-dioxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl]-4-isopropyl-5-methyl-4-(methyldisulfanyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-7,10,12,14-tetraene-3,6-dione

C33H36N6O7S2 (692.2087)


   

4-{2-methoxy-3,6-dioxo-5-[(2-phenylacetyl)oxy]-4-{4-[(2-phenylacetyl)oxy]phenyl}cyclohexa-1,4-dien-1-yl}phenyl 2-phenylacetate

4-{2-methoxy-3,6-dioxo-5-[(2-phenylacetyl)oxy]-4-{4-[(2-phenylacetyl)oxy]phenyl}cyclohexa-1,4-dien-1-yl}phenyl 2-phenylacetate

C43H32O9 (692.2046)


   

(4r,5s,17r,19s,20r)-8,20-dihydroxy-19-(hydroxymethyl)-5-(4-hydroxyphenyl)-7,9-dimethoxy-19-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,15,18-trioxatetracyclo[15.2.1.0⁴,¹³.0⁶,¹¹]icosa-6(11),7,9,12-tetraene-3,14-dione

(4r,5s,17r,19s,20r)-8,20-dihydroxy-19-(hydroxymethyl)-5-(4-hydroxyphenyl)-7,9-dimethoxy-19-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,15,18-trioxatetracyclo[15.2.1.0⁴,¹³.0⁶,¹¹]icosa-6(11),7,9,12-tetraene-3,14-dione

C32H36O17 (692.1952)